Extended studies on the viability of Mycobacterium leprae outside the human body
- PMID: 8637382
Extended studies on the viability of Mycobacterium leprae outside the human body
Abstract
Very little is known in leprosy regarding the transmission of the infection from the source to the susceptible host. One of the important factors which governs the transmission of the disease is the viability of Mycobacterium leprae outside the human body. In this study M. leprae obtained from untreated patients have been subjected to several adverse conditions. Their viability was verified by their multiplication in the footpads of normal mice. After drying in the shade the organisms were viable up to 5 months. On wet soil, they remained alive for 46 days. Kept in saline at room temperature, the organisms lived for 60 days. Surprisingly on exposure to direct sunlight for 3 hours a day the bacteria survived for 7 days. On refrigeration at 4 degrees C, the bacteria could be preserved for 60 days. On the other hand, keeping at -70 degrees C, the bacteria could be maintained in a living condition for only 28 days. On exposure to antiseptics like Savlon (R) and alcohol, the bacteria were rapidly killed. These results indicate the survival outside the human body of M. leprae under different environmental conditions in India where the disease is endemic. Transmission of infection by indirect contact and occurrence of new cases in the absences of any known source, are consistent with M. leprae being viable outside the human body for varying periods of time. The findings could also be pointers to understand the epidemiology of leprosy.
Similar articles
-
Effect of cryo preservation on Mycobacterium leprae growth in the footpads of non-immunosuppressed mice.Lepr Rev. 2007 Dec;78(4):381-5. Lepr Rev. 2007. PMID: 18309712
-
Viability of M. leprae under normal and adverse atmospheric conditions.Lepr India. 1982 Apr;54(2):228-33. Lepr India. 1982. PMID: 6752575
-
The role of free-living pathogenic amoeba in the transmission of leprosy: a proof of principle.Lepr Rev. 2008 Dec;79(4):401-9. Lepr Rev. 2008. PMID: 19274986
-
HLA and leprosy in the pre and postgenomic eras.Hum Immunol. 2006 Jun;67(6):439-45. doi: 10.1016/j.humimm.2006.03.009. Epub 2006 Apr 3. Hum Immunol. 2006. PMID: 16728267 Review.
-
The mouse foot-pad technique for cultivation of Mycobacterium leprae.Lepr Rev. 2006 Mar;77(1):5-24. Lepr Rev. 2006. PMID: 16715686 Review.
Cited by
-
How should Indonesia consider its neglected tropical diseases in the COVID-19 era? Hopes and challenges (Review).Biomed Rep. 2021 Jun;14(6):53. doi: 10.3892/br.2021.1429. Epub 2021 Apr 6. Biomed Rep. 2021. PMID: 33884196 Free PMC article. Review.
-
Mycobacterium leprae Infection in Ticks and Tick-Derived Cells.Front Microbiol. 2021 Oct 27;12:761420. doi: 10.3389/fmicb.2021.761420. eCollection 2021. Front Microbiol. 2021. PMID: 34777315 Free PMC article.
-
Leprosy.BMJ Clin Evid. 2010 Jun 28;2010:0915. BMJ Clin Evid. 2010. PMID: 21418690 Free PMC article.
-
The Mycobacterium tuberculosis virulence factor trehalose dimycolate imparts desiccation resistance to model mycobacterial membranes.Biophys J. 2008 Jun;94(12):4718-24. doi: 10.1529/biophysj.107.125542. Epub 2008 Mar 7. Biophys J. 2008. PMID: 18326657 Free PMC article.
-
Pathogenicity and virulence of Mycobacterium leprae.Virulence. 2022 Dec;13(1):1985-2011. doi: 10.1080/21505594.2022.2141987. Virulence. 2022. PMID: 36326715 Free PMC article. Review.